CytoDyn Inc. (CYDY) Social Stream



CytoDyn Inc. (CYDY): $0.41

0.02 (+4.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CYDY to Watchlist
Sign Up

Industry: Biotech


Ranked

of 405

in industry

Featured Post From StockTwits About CYDY

$CYDY I think Dr. P is a POS and a fraud. However, if this is true and CYDY essential lied about the patent being canceled then Nader/Kelly are dumber than I thought since it is something anyone can confirm.

The Company’s Lawsuit further alleges that Dr. Patterson has attempted to patent certain uses of Leronlimab as his own, which was rejected by the U.S. Patent and Trademarks Office (the “USPTO”). This is false, as Dr. Patterson has not attempted to do so. Patent applications have been submitted by IncellDx, not Dr. Patterson, in connection with certain uses of CCR5 antagonists in COVID-19. The Participants understand that those patents are currently pending before the USPTO and have not been rejected (contrary to the assertions of the Company in the Lawsuit) and have been advised by IncellDx that they do not directly conflict with patents held solely by the Company.
diggingforalpha, published August 17, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.7847 seconds.